Consumer Staples · NYSE: CLX
Clorox: how the business works
Clorox makes bleach, Glad bags, Brita filters and, since April 2026, Purell hand sanitizer, with $6.72 billion of net sales in FY2026.
By Hardik Bhandare · Checked against filings: . Editorial policy. Corrections
Follow Clorox
Email me when Clorox's page is updated after earnings.
We'll send a confirmation email first. See our privacy policy.
The Clorox Company · Oakland, California · Founded 1913
Updated for Q1 FY2027 · checked
- Net sales, FY2026
- $6.72B
- Net income attributable to Clorox, FY2026
- $587M
- Walmart's share of net sales, FY2026
- 26%
- Employees, Jun 30, 2026
- About 9,200
- Founded
- 1913
The short version
Clorox in 5 points
1 · What it sells
Clorox sells household brands such as Clorox bleach and wipes, Glad bags, Kingsford charcoal, Brita and, since Apr 1, 2026, Purell, with $6,720 million of net sales in FY2026.
2 · Who pays it
Walmart accounted for 26% of Clorox's FY2026 net sales, its next four largest customers for about 24% and all other customers for about 50%.
3 · What it keeps from $100
Of every $100 that came in during FY2026, Clorox kept $8.72 as net income, which includes $8 million of non-operating other income, net; Clorox reports no operating income line, and EBIT, a non-GAAPThe company's own "adjusted" numbers, not the official (GAAP) ones. Always read them next to the official figure. Learn more measure Clorox reports, was $913 million.
4 · Where the operating profit comes from
Health and Wellness, the cleaning and Purell segment, earned $678 million, about 57%, of the $1,191 million of FY2026 segment adjusted EBIT from Clorox's four segments.
5 · The one thing to watch
On Nov 2, 2026 Clorox said it now expects FY2027 gross margin of about 41.5%, against about 42% in its Aug 3, 2026 outlook, after a Q1 FY2027 gross margin of 40.4%.
Sources: From Clorox's FY2026 10-K and its Q4 FY2026 and Q1 FY2027 earnings releases · checked
Sources (6)
01Where the money goes · FY2026
Where does $100 of Clorox's money go?
Clorox · FY2026
Receipt for every $100
| Cost of products sold | $57.6 |
|---|---|
| Selling, administration and research | $17.6 |
| Advertising | $11.1 |
| Interest and income taxes | $4.8 |
| Share of outside partners | $0.2 |
| Kept as net income | $8.7 |
| Total | $100 |
Each line = amount ÷ total money in × 100. Lines may not add to exactly $100 because of rounding.
How this is worked out
Cityfort calculation from the FY2026 10-K. Of every $100 that came in during FY2026 (net sales of $6,720 million plus $8 million of other income, net): each line = line ÷ $6,728 million × 100.
Save this receipt as an image
Embed this receipt or the key numbers
Paste this code into a blog or website to show the card you choose, with a link back to this page.
Each week: the next company due to report earnings, explained in 5 points.
No tips. Unsubscribe anytime.
We'll send a confirmation email. See our privacy policy.
02The business in one line
What does Clorox do?
Shoppers buy Clorox brands at Walmart and other stores; most of the money goes on making the products and advertising them, and Clorox kept $8.72 of every $100 as net income in FY2026.
- Walmart alone paid for 26% of Clorox's FY2026 net sales, and the five largest customers for about half.
- Making the products took $57.61 of every $100 in FY2026, and advertising took $11.13.
03Who pays it
Who pays Clorox?
Walmart
26%
of revenue
Walmart Stores and its affiliates buy across all four segments. They were Clorox's largest customer, at 26% of FY2026 net sales, 27% in FY2025 and 25% in FY2024.
Other retailers in the US
Share of revenue not disclosed
Grocery chains, warehouse clubs, dollar stores, hardware, drug and pet stores, the military and online sellers. No other single customer reached 10% of net sales in FY2026.
Professional buyers
8%
of revenue
Hospitals, schools, offices and restaurants, mostly reached through distributors. Professional products were 8% of FY2026 net sales, up from 5%, after GOJO joined.
Buyers outside the US
17%
of revenue
Retailers and distributors in the International segment, which was 17% of FY2026 net sales.
- Walmart26%
- Professional buyers8%
- Buyers outside the US17%
Customer concentration
Walmart alone was 26% of FY2026 net sales; the 10-K says the five largest customers were about half of net sales in each of FY2024, FY2025 and FY2026.
- Largest customer
- 26%
- Top 5 customers
- 50%
04How it makes money
How does Clorox make money?
Clorox earns from brands that shoppers buy again and again, at prices above store brands.
Clorox says over 80% of its sales come from brands that are No. 1 or No. 2 in their categories, and that its products compete on performance and brand reputation, among other things. It spent $749 million on advertising in FY2026. Gross profit per $100 of sales was $35.8 in FY2022, when product costs rose, and $45.2 in FY2025.
Gross profit per $100 of net sales
$35.8$42.3
FY2022 to FY2026
- Advertise brands such as Clorox, Glad and Brita
- Shoppers buy the brand instead of a store brand
- Retailers such as Walmart stock the brands
- Steady repeat sales cover factory and ad costs
- Gross profit pays for more advertising and dividends
↺ Step 5 feeds back into step 1.
05Business segments · FY2026
Which businesses make up Clorox?
Health and Wellness
40.1%Cleaning, Purell and professional products. Segment adjusted EBIT, Clorox's segment profit measure, was $678 million, $25.1 per $100 of sales (Cityfort calculation from the FY2026 10-K).
Revenue $2.7B ($2,697M) · Operating profit $678M
Household
26.6%Glad, cat litter and Kingsford charcoal. Net sales fell 11% in FY2026 and segment adjusted EBIT fell from $325 million to $192 million.
Revenue $1.8B ($1,787M) · Operating profit $192M
Lifestyle
16.7%Hidden Valley, Brita and Burt's Bees. Net sales fell 14% in FY2026, the largest drop of the four.
Revenue $1.1B ($1,123M) · Operating profit $208M
International
16.6%Sales outside the US. The only segment with organic growth (growth leaving out acquisitions, business sales and currency) in FY2026, at 2%.
Revenue $1.1B ($1,113M) · Operating profit $113M
How the mix changed
- Health and Wellness
- Household
- Lifestyle
- International
Revenue by segment, FY2023 to FY2026.
US$
See the numbers
06The numbers · Consolidated · US$
How has Clorox done?
Revenue
$6.7BFY2026
Net sales fell 5% to $6,720 million in FY2026, as retailers ran down stock they had built before Clorox switched its US ordering systems in 2025.
US$
See the numbers
Net income
$587MFY2026
Net income attributable to Clorox ranged from $149 million in FY2023, a year with $445 million of impairments, to $810 million in FY2025, then fell to $587 million in FY2026.
US$
See the numbers
Net income for every $100 of revenue
$8.7FY2026
Clorox reports no operating income line, so EBITDA is a Cityfort calculation from the FY2022 to FY2026 10-Ks and the earnings releases (earnings before taxes, plus interest expense less interest income, plus depreciation and amortization). It was $17.3 per $100 of net sales in FY2026, down from $19.4 in FY2025.
Net margin: $ of net income per $100 of revenue
See the numbers
Free cash flow
$405MFY2026
Free cash flow fell to $405 million in FY2026 from $761 million, partly because the $476 million paid to P&G for its 20% share of Glad counted as operating cash outflow.
US$ · cash from operations minus spending on plants and equipment
See the numbers
See all yearly numbers
EBITDA here = operating income plus depreciation and amortization (from the cash flow statement). Fiscal years are the company's own: Fiscal year ends June 30; FY2026 is the year ended Jun 30, 2026, and Q1 FY2027 the quarter ended Sep 30, 2026. Net income is the share belonging to the company's owners.
Learn: Fiscal years that don't end in December: Nvidia's FY2027 explained · Stock-based compensation and dilution: pay that becomes shares
Sources (27)
- Form 10-K FY2022 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2023 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2024 Exhibit 99.1 (MD&A and financial statements)
- 8-K Ex. 99.1 earnings press release Q4 FY2025
- Form 10-K FY2025 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2026 Exhibit 99.1 (MD&A and financial statements)
- 8-K Ex. 99.1 earnings press release Q4 FY2026
- 8-K Ex. 99.2 supplemental information Q4 FY2026
- Form 10-Q for Q2 FY2024
- Form 10-Q for Q3 FY2024
- Form 10-Q for Q1 FY2025
- 8-K Ex. 99.1 earnings press release Q1 FY2026
- 8-K Ex. 99.2 supplemental information Q1 FY2026
- Form 10-Q for Q2 FY2025
- 8-K Ex. 99.1 earnings press release Q2 FY2025
- 8-K Ex. 99.2 supplemental information Q2 FY2026
- Form 10-Q for Q3 FY2025
- 8-K Ex. 99.1 earnings press release Q3 FY2025
- 8-K Ex. 99.2 supplemental information Q3 FY2026
- Form 10-Q Q1 FY2026 (Sep 30, 2025)
- Form 10-Q Q2 FY2026 (Dec 31, 2025)
- 8-K Ex. 99.1 earnings press release Q2 FY2026
- Form 10-Q Q3 FY2026 (Mar 31, 2026)
- 8-K Ex. 99.1 earnings press release Q3 FY2026
- Form 10-Q Q1 FY2027 (quarter ended Sep 30, 2026)
- 8-K Ex. 99.1 earnings press release Q1 FY2027
- 8-K Ex. 99.2 supplemental information Q1 FY2027
07Who runs it
Who runs Clorox, and did they deliver?
Linda Rendle
Chair and Chief Executive Officer · since 2020
CEO since Sep 2020 and Chair since Jan 2024; the 2026 proxy says she has served 23 years at Clorox, six of them as CEO. On May 28, 2026 Clorox announced she had asked the Board to start a CEO search for health reasons. On Oct 28, 2026 the Board named Fabian Garcia as her successor; she steps down as CEO and Chair on Jan 5, 2027 and stays as a senior advisor through Apr 2, 2027.
Fabian Garcia
Chief Executive Officer (from Jan 5, 2027) · since 2027
Appointed by the Board on Oct 28, 2026 as CEO and director, effective Jan 5, 2027. He has been Business Group President, Personal Care at Unilever since 2022, and was CEO of Revlon from 2016 to 2018.
Luc Bellet
Executive Vice President and Chief Financial Officer · since 2025
CFO since Apr 2025; previously Clorox treasurer.
Chris Hyder
Executive Vice President and Chief Operating Officer · since 2026
COO since Jun 2026.
Nina Barton
Executive Vice President and Chief Growth and Strategy Officer · since 2026
In the role since Jun 2026.
Carey Jaros
President, Clorox Purell · since 2026
Leads the former GOJO business, based in Akron, Ohio, since the Apr 1, 2026 acquisition.
What they said, and what happened
1 delivered · 1 missed · 2 too early to tell
Said on Apr 30, 2026
On Apr 30, 2026, with GOJO included, management said FY2026 net sales would fall about 6%, with diluted EPS of $4.78 to $4.98 and adjusted EPS of $5.45 to $5.65.
DeliveredWhat happened
FY2026 net sales fell 5%, diluted EPS was $4.81 and adjusted EPS $5.53.
Said on Feb 3, 2026
On Feb 3, 2026, before the GOJO deal closed, management said FY2026 diluted EPS would be $5.60 to $5.95 and adjusted EPS $5.95 to $6.30.
MissedWhat happened
Diluted EPS was $4.81 and adjusted EPS $5.53. The Apr 30, 2026 outlook had already lowered the ranges and added GOJO.
Said on Jan 22, 2026
When it agreed to buy GOJO, Clorox said the deal should produce at least $50 million of yearly cost savings once fully in place.
Too early to tellWhat happened
The filings read do not report savings achieved so far.
Said on Aug 3, 2026
On Aug 3, 2026, management said FY2027 adjusted EPS would be $5.70 to $6.00.
Too early to tellWhat happened
On Nov 2, 2026 it kept the range but said results would be closer to the low end.
Sources (9)
- Form 10-K FY2026 (fiscal year ended June 30)
- DEF 14A proxy statement 2026
- 8-K CEO succession (Item 5.02), filed Oct 29, 2026
- 8-K Ex. 99.1 GOJO acquisition completed (Apr 1, 2026)
- 8-K Ex. 99.1 earnings press release Q3 FY2026
- 8-K Ex. 99.1 earnings press release Q4 FY2026
- 8-K Ex. 99.1 earnings press release Q2 FY2026
- 8-K Ex. 99.1 GOJO acquisition announced (Jan 22, 2026)
- 8-K Ex. 99.1 earnings press release Q1 FY2027
08What could go wrong
What could go wrong for Clorox?
- Concentration
One customer buys a quarter of its products
Walmart was 26% of FY2026 net sales, and the five largest customers about half. Losing shelf space or facing tougher terms at one of them would hit sales.
Watch Walmart's share of net sales in the next 10-K.
- Debt
More debt after the GOJO deal
Net debt rose from $2.3 billion to $4.9 billion in FY2026, and S&P cut its rating to BBB. The 10-K says further downgrades could follow if Clorox cannot reduce leverage.
Watch Net debt and any rating action by S&P or Moody's.
- Execution
Integrating Purell
Clorox paid about $2.1 billion for GOJO. When it announced the deal on Jan 22, 2026, it said it expected at least $50 million of yearly cost savings. The 10-K lists integrating recent acquisitions among its risks.
Watch Health and Wellness organic growth and segment profit each quarter.
- Raw-material prices
Raw material and cost inflation
Resin, chemicals, soybean oil and packaging drive costs. In Nov 2026 management said the cost environment had become more challenging and cut its FY2027 gross margin outlook to about 41.5%.
Watch Gross margin each quarter against the company's outlook.
- Demand
Shoppers buying less
Organic volume fell 7% in FY2026. Management said in Aug 2026 it expects a value-seeking consumer, and store brands compete on price.
Watch Organic volume growth by segment.
- Execution
Leadership change
The CEO asked the Board in May 2026 to find her successor for health reasons. On Oct 28, 2026 the Board appointed Fabian Garcia, at Unilever since 2020, as CEO from Jan 5, 2027. Several other senior roles changed in 2025 and 2026.
Watch The CEO hand-over to Fabian Garcia on Jan 5, 2027.
- Other
Burt's Bees brand value
The Burt's Bees trademark is carried at $322 million. In the FY2026 review, its estimated fair value was no more than 20% above that, and a lower estimate would mean an impairment charge (a write-down of its value).
Watch Impairment charges in the 10-K or 10-Qs.
Sources (8)
- Form 10-K FY2026 (fiscal year ended June 30)
- Form 10-K FY2026 Exhibit 99.1 (MD&A and financial statements)
- 8-K Ex. 99.1 GOJO acquisition announced (Jan 22, 2026)
- 8-K Ex. 99.1 earnings press release Q1 FY2027
- 8-K Ex. 99.1 earnings press release Q4 FY2026
- DEF 14A proxy statement 2026
- 8-K CEO succession (Item 5.02), filed Oct 29, 2026
- Form 10-Q Q1 FY2027 (quarter ended Sep 30, 2026)
09Supporters vs. critics
What do supporters and critics point to?
What supporters point to
- Clorox says over 80% of its sales come from brands holding the No. 1 or No. 2 market share position in their categories.
- Purell joined on Apr 1, 2026, and Health and Wellness net sales rose 62% in Q1 FY2027, with organic growth of 23%.
- Q1 FY2027 net sales rose 33% to $1.91 billion; Clorox says about 18 points of its 18% organic growth came from lapping the retailer stock drawdown of a year earlier.
- International was the only segment with organic growth in FY2026, at 2%, and its net sales rose 11% in Q1 FY2027.
- Clorox declared $4.96 of dividends per share in FY2026, up from $4.88, and raised its quarterly dividend 1% to $1.25 on Jul 31, 2026.
What critics point to
- Walmart bought 26% of FY2026 net sales and the five largest customers about half; the same retailers sell store brands that compete with Clorox on price.
- Net debt rose from $2.3 billion to $4.9 billion in FY2026, and S&P's long-term rating fell from BBB+ to BBB.
- FY2026 net sales fell 5% and organic volume fell 7%; Household sales fell 11% and Lifestyle sales 14%.
- FY2026 dividends paid of $602 million exceeded the $587 million of net income attributable to Clorox, and Clorox's own stockholders' equity fell to $90 million.
- The chief executive is changing: Linda Rendle asked the Board in May 2026 to find a successor for health reasons, and Fabian Garcia, at Unilever since 2020, takes over on Jan 5, 2027.
10What to watch next
What should you watch next at Clorox?
Next event
Q2 FY2027 results
Feb 3, 2027
Expected, based on last year's date
Gross margin against the outlook
Management said on Nov 2, 2026 that it now expects FY2027 gross margin of about 41.5%, against about 42% in its Aug 3, 2026 outlook. Q1 FY2027 gross margin was 40.4%, down 130 basis points (1.3 percentage points).
Purell savings and debt
When it agreed to buy GOJO on Jan 22, 2026, Clorox said it expected at least $50 million of yearly cost savings once fully in place. Net debt was $4,974 million at Sep 30, 2026 (Cityfort calculation from the Q1 FY2027 10-Q).
A new chief executive
Fabian Garcia, appointed by the Board on Oct 28, 2026, takes over as CEO from Linda Rendle on Jan 5, 2027, when Matthew Shattock becomes Independent Chair.
11Key facts
Key facts about Clorox
- What does Clorox do?
- The Clorox Company, based in Oakland, California, makes household products such as Clorox bleach and wipes, Glad bags, Fresh Step cat litter, Kingsford charcoal, Hidden Valley dressing, Brita filters and Burt's Bees. Clorox bought GOJO, the maker of Purell hand sanitizer, on Apr 1, 2026.
- How does Clorox make money?
- Clorox makes money by selling its brands to retailers, which resell them to shoppers. In FY2026 (the year to Jun 30, 2026), Health and Wellness, the cleaning and Purell segment, was the largest of Clorox's four segments, at $2,697 million or 40.1% of $6,720 million of net sales.
- Which Clorox segment earns the most?
- Clorox's Health and Wellness segment earned $678 million of segment adjusted EBIT in FY2026, about 57% of the $1,191 million the four segments earned combined (Cityfort calculation from the FY2026 10-K).
- Who are Clorox's customers?
- Walmart and its affiliates were Clorox's largest customer, at 26% of FY2026 net sales. Clorox's FY2026 10-K says its five largest customers were about half of net sales, which leaves about 24% for the other four and about 50% for all other customers (Cityfort calculation from the FY2026 10-K).
- How big is Clorox?
- Clorox had FY2026 net sales of $6,720 million, down 5% from $7,104 million in FY2025, and net income attributable to Clorox of $587 million, down from $810 million. Clorox had about 9,200 employees at Jun 30, 2026.
- Who owns Clorox?
- No single holder controls Clorox. In the filings listed in Clorox's 2026 proxy statementThe yearly filing about shareholder votes, the board and executive pay. Learn more, BlackRock held 8.23%, Vanguard Capital Management 7.35% and State Street 6.95% of the shares, and Clorox's directors and executive officers as a group held 0.51%.
- How much debt does Clorox have?
- Clorox's debt exceeded its cash by $4,925 million at Jun 30, 2026, up from $2,321 million a year earlier, after Clorox paid about $2.1 billion for GOJO and $476 million for P&G's 20% share of Glad (Cityfort calculation from the FY2026 10-K).
- Does Clorox pay a dividend?
- Clorox declared dividends of $4.96 per share in FY2026, up from $4.88 in FY2025. Clorox paid $602 million in dividends in FY2026, more than its $587 million of net income attributable to Clorox.
Terms on this page
- Capital expenditures (capex)
- Customer concentration
- Debt-to-equity
- Earnings per share (EPS)
- EBITDA
- Free cash flow
- Interest coverage
- Net debt
- Net margin
- Revenue vs net income
Each explains the term in plain English, with the same number from other companies on Cityfort.
Go deeper
More detail from the same filings. Open any section.
12What it sells
12What it sells
What does Clorox sell?
Health and Wellness
Cleaning products such as Clorox bleach and wipes, Pine-Sol, Formula 409 and Liquid-Plumr, plus Purell and GOJO soap and sanitizer and CloroxPro products for hospitals, schools and offices. $2,697 million of net sales in FY2026.
Household
Glad trash bags and food wraps, Fresh Step and Scoop Away cat litter, and Kingsford charcoal, sold in the US. $1,787 million of net sales in FY2026.
Lifestyle
Hidden Valley ranch dressing and sauces, Brita water filters and Burt's Bees lip balm and skin care, sold in the US. $1,123 million of net sales in FY2026.
International
Clorox, Poett, Pine-Sol, Clorinda, Chux, Glad and other brands sold outside the US. $1,113 million of net sales in FY2026.
What it does
- Does: Makes and markets branded products that shoppers use up and buy again
- Does: Sells mostly to retailers, which then sell to shoppers
- Does: Sells to hospitals, schools and restaurants through distributors, mainly via Purell and CloroxPro
What it does not do
- Does not: Does not run its own shops: mass retailers, grocers, warehouse clubs, dollar stores and online sellers stock its products
- Does not: Does not earn most of its money abroad: 84% of FY2026 net sales were in the US
- Does not: Does not report an operating income line in its income statement
13How the money flows
13How the money flows · FY2026
How does money flow through Clorox?
Money in
- Net sales$6.7B
- Other income, net$8M
The company
Clorox
$6.7B came in
Money out
- Cost of products sold$3.9B
- Selling, administration and research$1.2B
- Advertising$749M
- Interest$130M
- Income taxes$190M
- Share of outside partners$14M
- Net income attributable to Clorox$587M
- Shoppers buy Clorox brands at Walmart and other stores; Clorox booked $6,720 million of net sales in FY2026.
- Making the products took $3,876 million: chemicals, plastic resin, cardboard, soybean oil and factory costs.
- Clorox spent $749 million on advertising and $1,182 million on selling, administration and research.
- Interest of $130 million and taxes of $190 million came next, and $14 million went to outside partners.
- The $587 million left was net income attributable to Clorox, less than the $602 million it paid out in dividends.
14What it needs to run
14What it needs to run
What does Clorox need to run?
Raw materials and packaging
Plastic resin for bags, non-woven fabric for wipes, sodium hypochlorite for bleach, cardboard, soybean oil and other chemicals. The 10-K says some come from a single supplier.
Advertising
Clorox spent $749 million on advertising in FY2026, $11.1 per $100 of net sales (Cityfort calculation from the FY2026 10-K).
People and research
About 9,200 employees at Jun 30, 2026, 77% in the US. Its main research campus is in Pleasanton, California; research cost $116 million in FY2026.
Ordering and supply systems
Clorox finished moving its US business to a new cloud-based ERP system, the software that runs orders, stock and invoicing, in Q3 FY2026. It says the digital program cost about $580 million.
15Where it sells
15Where it sells · FY2026
Where does Clorox sell?
- United States83.8%
- Outside the US16.2%
16Where growth could come from
16Where growth could come from
Where could Clorox's growth come from?
Management said in the Nov 2, 2026 earnings release that it still expects FY2027 net sales to grow 13% to 14%, about 9.5 points of it from GOJO. It still expects adjusted EPS of $5.70 to $6.00, with results closer to the low end of that range.
Purell (GOJO)
New39 points of Health and Wellness growth, Q1 FY2027
GOJO joined on Apr 1, 2026. Health and Wellness net sales rose 62% in Q1 FY2027; 39 points came from the acquisition and organic growth was 23%.
Status: New, recently announced.
Sales after the systems switch
MixedOrganic sales +18%, Q1 FY2027
Retailers stocked up before the 2025 ERP switch, then ran stock down in FY2026. Clorox says about 18 points of the Q1 FY2027 organic growth came from lapping that drawdown (the quarter a year earlier included it).
Status: Mixed, partly on track.
International
WorkingOrganic sales +2% in FY2026, +9% in Q1 FY2027
The only segment that grew organically in FY2026. In Q1 FY2027 its net sales rose 11%, led by Latin America, the release says.
Status: Working, on track against what the company said.
Professional customers
Early8% of FY2026 net sales, up from 5%
In October 2026 Clorox launched Clorox Purell ProCare, combining CloroxPro and GOJO under one sales and service team for professional and healthcare buyers.
Status: Early, too early to judge.
Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.
17The company's own measures (non-GAAP)
17The company's own measures · FY2025 to Q1 FY2027
What do Clorox's own measures show?
Official (GAAP): Diluted EPS, FY2026
$4.81
Company's own measure: Adjusted EPS, FY2026
$5.53
Clorox's own measure. It leaves out GOJO acquisition and integration costs and the cost of its digital capabilities and productivity investment.
Official (GAAP): Diluted EPS, FY2025
$6.52
Company's own measure: Adjusted EPS, FY2025
$7.72
Leaves out the $118 million loss on selling the Better Health vitamins business, $70 million of cyberattack insurance recoveries and digital investment costs.
Official (GAAP): Earnings before income taxes, FY2026
$791M
Company's own measure: Adjusted EBIT, FY2026
$1.0B
Adds back interest, $58 million of GOJO acquisition and integration costs and $59 million of digital investment costs.
Official (GAAP): Free cash flow, FY2026
$405M
Company's own measure: Adjusted free cash flow, FY2026
$881M
Clorox adds back the $476 million Glad payment to P&G to its free cash flowCash from operations minus spending on buildings and equipment. Learn more. Free cash flow here is operating cash flow less capital spending.
Official (GAAP): Net sales growth, FY2026
−5.0%
Company's own measure: Organic sales growth, FY2026
−8%
Leaves out the effect of acquisitions, divestitures and currency, so GOJO is excluded.
Official (GAAP): Diluted EPS, Q1 FY2027
$1.39
Company's own measure: Adjusted EPS, Q1 FY2027
$1.55
Leaves out GOJO acquisition and integration costs, among other items.
These are the company's own measures, defined by the company. They are not comparable across companies, and they are not added together. Each sits beside the nearest official (GAAP) figure.
Learn: Non-GAAP measures: what a company's "adjusted" numbers leave out
18Financial strength and debt
18Financial strength · Jun 30, 2026
How much debt does Clorox have?
- Total debt$5.1B
- Cash and investments$143M
- Net debt (debt minus cash)$4.9B
- Net worth (shareholders' money)$90M
- Debt to equity
- 56.31×
- $ of debt for every $1 of shareholders' money
- Interest cover
- 7×
- how many times operating profit covers interest
- Debt is notes and loans payable ($1,086 million of commercial paper and credit-line borrowings), current maturities ($1 million) and long-term debt ($3,981 million). Net debt, net debt to EBITDA and interest cover (earnings before interest and taxes of $913 million ÷ interest expense of $130 million) are a Cityfort calculation from the FY2026 10-K.
- Net debt rose from $2,321 million a year earlier, after Clorox paid about $2.1 billion for GOJO and $476 million for P&G's 20% share of Glad. In May 2026 it sold $1.5 billion of new notes.
- Lease liabilities of $452 million are not counted as debt here.
- Clorox's own stockholders' equity was only $90 million, down from $321 million, after $602 million of dividends and $256 million of buybacks in FY2026; that is why debt-to-equity reads 56.3.
- Clorox states that current liabilities exceeded current assets by $949 million at Jun 30, 2026, mainly due to credit obligations due within a year. Its $1,964 million of revolving credit lines were undrawn.
- At Sep 30, 2026, debt was $5,158 million and cash $184 million, so net debt was $4,974 million (Cityfort calculation from the Q1 FY2027 10-Q).
19Who owns it
19Who owns it · ownership as of Aug 31, 2026
Who owns Clorox?
- Officers and directors (as a group), shares
- 0.5%
Share classes
Holders of 5% or more
From the company's proxy statement (DEF 14A), later Schedule 13G filings and the share counts on its latest annual or quarterly report. Each holder row shows the date of its own filing.
Learn: How to read a proxy statement (DEF 14A): Nvidia's 2026 proxy · Form 4 insider filings: who files, the codes and the footnotes
Sources (1)
20What it does with profit
20What it does with profit
What does Clorox do with its profit?
Dividend per share
$4.96FY2026
Dividend paid for each share, by financial year.
$ per share
See the numbers
Buyback · Jun 30, 2022
FY2022: bought back its own shares for $25 million.
$25M
Buyback · Jun 30, 2025
FY2025: bought back its own shares for $332 million.
$332M
Buyback · Jun 30, 2026
FY2026: bought back its own shares for $256 million.
$256M
Money raised · May 11, 2026
Sold $1.5 billion of senior notes due 2031, 2033 and 2036; the $1.25 billion term loan drawn for GOJO in April 2026 was settled in May.
$1.5B
Sources (6)
- Form 10-K FY2022 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2023 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2024 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2025 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2026 Exhibit 99.1 (MD&A and financial statements)
- 8-K debt offering (Item 8.01), May 11, 2026
21Governance signals
21Governance signals
What do Clorox's governance filings show?
- Auditor
- Ernst & Young LLP, since 2003
- Auditor changes
- None in the period covered
- Audit qualifications
- None reported
- Related-party dealings
- The 2026 proxy says Clorox reviews all transactions with directors, officers and their families and does not believe any had a material interest in them. The 10-K reports equity investments of $48 million in partly owned businesses, mainly contract manufacturers and raw material suppliers.
- Credit rating
- S&P Global Ratings and Moody's (as stated in Clorox's FY2026 10-K) BBB long-term, A-2 short-term (S&P) / Baa1 long-term, P-2 short-term (Moody's) (outlook Not stated in the 10-K), Jun 30, 2026
A credit rating describes the company's ability to repay debt. It is not a rating of the share.
Flags to know about
other
S&P lowered its rating in FY2026
S&P's long-term rating was BBB at Jun 30, 2026, against BBB+ a year earlier; Moody's held Baa1. Clorox's 10-K warns that further downgrades could follow if it cannot reduce leverage, improve results or integrate recent acquisitions.
other
New chief executive from Jan 5, 2027
An 8-K filed Oct 29, 2026 says the Board appointed Fabian Garcia as CEO and a director, effective Jan 5, 2027. Linda Rendle steps down as CEO and Chair on that date and stays as a senior advisor through Apr 2, 2027; Lead Independent Director Matthew Shattock becomes Independent Chair.
disclosure
What Clorox does not report
The FY2026 10-K names no competitor and no customer other than Walmart, and Clorox files no earnings-call transcripts with the SEC. The date and outlook of the S&P rating change are not in the filings read.
other
Policy bars hedging Clorox stock
The 2026 proxy says Clorox policy bars directors and executive officers from hedging Clorox stock or using it as loan collateral.
22How it got here
22How it got here
How did Clorox get here?
1913
Milestone
Founded in Oakland
Clorox was founded in Oakland, California, where it is still based.
2023
Crisis
Cyberattack disrupts operations
An attack found on Aug 14, 2023 caused wide-scale disruption and cut sales and earnings in FY2024 before operations returned to normal.
2024
Milestone
Leaves Argentina
Clorox sold its Argentina business in FY2024, booking a $240 million loss.
2025
Milestone
Sells vitamins business
The Better Health vitamins business was sold in FY2025 for $128 million, with a $118 million loss.
2025
Business-model change
New US ordering system
Retailers stocked up before the 2025 ERP switch, adding about 3.5 points to FY2025 sales; running that stock down cut FY2026 sales by about 7.5 points.
2026
Business-model change
Takes full control of Glad
The Glad venture with P&G ended on Jan 31, 2026, and Clorox bought P&G's 20% share for $476 million.
2026
Business-model change
Buys GOJO, maker of Purell
Announced Jan 22, 2026 and completed Apr 1, 2026 for about $2.1 billion in cash, funded with commercial paper and new debt.
2026
Milestone
CEO search begins
On May 28, 2026 Clorox announced that CEO Linda Rendle had asked the Board to find a successor.
2026
Milestone
New CEO named
On Oct 28, 2026 the Board appointed Fabian Garcia as CEO, effective Jan 5, 2027, when Linda Rendle steps down and Matthew Shattock becomes Independent Chair.
Sources (9)
- Form 10-K FY2026 (fiscal year ended June 30)
- Form 10-K FY2026 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2024 Exhibit 99.1 (MD&A and financial statements)
- Form 10-K FY2025 Exhibit 99.1 (MD&A and financial statements)
- 8-K Ex. 99.1 earnings press release Q4 FY2026
- DEF 14A proxy statement 2026
- 8-K Ex. 99.1 GOJO acquisition announced (Jan 22, 2026)
- 8-K Ex. 99.1 GOJO acquisition completed (Apr 1, 2026)
- 8-K CEO succession (Item 5.02), filed Oct 29, 2026
23Sources and changes
Where every number on this page comes from
Sources (33 documents)
- S1Form 10-K FY2026 (fiscal year ended June 30) · SEC EDGAR · Tier 1: company or exchange filing · Aug 7, 2026
- S2Form 10-K FY2026 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 7, 2026
- S4Form 10-K FY2025 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 8, 2025
- S6Form 10-K FY2024 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 8, 2024
- S8Form 10-K FY2023 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 10, 2023
- S10Form 10-K FY2022 Exhibit 99.1 (MD&A and financial statements) · SEC EDGAR · Tier 1: company or exchange filing · Aug 10, 2022
- S11Form 10-Q Q1 FY2027 (quarter ended Sep 30, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Nov 2, 2026
- S12Form 10-Q Q3 FY2026 (Mar 31, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2026
- S13Form 10-Q Q2 FY2026 (Dec 31, 2025) · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2026
- S14Form 10-Q Q1 FY2026 (Sep 30, 2025) · SEC EDGAR · Tier 1: company or exchange filing · Nov 3, 2025
- S15DEF 14A proxy statement 2026 · SEC EDGAR · Tier 1: company or exchange filing · Oct 7, 2026
- S168-K Ex. 99.1 earnings press release Q1 FY2027 · SEC EDGAR · Tier 1: company or exchange filing · Nov 2, 2026
- S178-K Ex. 99.2 supplemental information Q1 FY2027 · SEC EDGAR · Tier 1: company or exchange filing · Nov 2, 2026
- S188-K Ex. 99.1 earnings press release Q4 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Aug 3, 2026
- S198-K Ex. 99.2 supplemental information Q4 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Aug 3, 2026
- S208-K Ex. 99.1 earnings press release Q3 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2026
- S218-K Ex. 99.2 supplemental information Q3 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2026
- S228-K Ex. 99.1 earnings press release Q2 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2026
- S238-K Ex. 99.2 supplemental information Q2 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2026
- S248-K Ex. 99.1 earnings press release Q1 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Nov 3, 2025
- S258-K Ex. 99.2 supplemental information Q1 FY2026 · SEC EDGAR · Tier 1: company or exchange filing · Nov 3, 2025
- S268-K Ex. 99.1 earnings press release Q4 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Jul 31, 2025
- S278-K Ex. 99.1 earnings press release Q3 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · May 5, 2025
- S288-K Ex. 99.1 earnings press release Q2 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2025
- S298-K Ex. 99.1 GOJO acquisition announced (Jan 22, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Jan 22, 2026
- S308-K Ex. 99.1 GOJO acquisition completed (Apr 1, 2026) · SEC EDGAR · Tier 1: company or exchange filing · Apr 1, 2026
- S328-K debt offering (Item 8.01), May 11, 2026 · SEC EDGAR · Tier 1: company or exchange filing · May 11, 2026
- S33Form 10-Q for Q3 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · May 5, 2025
- S34Form 10-Q for Q2 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Feb 3, 2025
- S35Form 10-Q for Q1 FY2025 · SEC EDGAR · Tier 1: company or exchange filing · Oct 30, 2024
- S36Form 10-Q for Q3 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Apr 30, 2024
- S37Form 10-Q for Q2 FY2024 · SEC EDGAR · Tier 1: company or exchange filing · Feb 1, 2024
- S388-K CEO succession (Item 5.02), filed Oct 29, 2026 · SEC EDGAR · Tier 1: company or exchange filing · Oct 29, 2026
Changes to this page (v1 · Nov 20, 2026)
- v1 · Nov 20, 2026First version. (first version)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.
Read the positions policyRead the full disclaimerHide the full disclaimer
Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.
All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.